These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3076123)

  • 1. The lipoprotein receptor concept.
    Bilheimer DW
    Drugs; 1988; 36 Suppl 3():55-62. PubMed ID: 3076123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic basis of familial hypercholesterolemia.
    Myant NB
    Klin Wochenschr; 1983 Apr; 61(8):383-401. PubMed ID: 6306334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein metabolism in familial hypercholesterolemia.
    Shepherd J; Packard CJ
    Arteriosclerosis; 1989; 9(1 Suppl):I39-42. PubMed ID: 2912431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low density lipoprotein receptor.
    Schneider WJ
    Biochim Biophys Acta; 1989 May; 988(2):303-17. PubMed ID: 2655710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.
    YU KC; Smith D; Yamamoto A; Kawaguchi A; Harada-Shiba M; Yamamura T; Mamo JC
    Clin Sci (Lond); 1997 Feb; 92(2):197-203. PubMed ID: 9059322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9.
    Ouguerram K; Chetiveaux M; Zair Y; Costet P; Abifadel M; Varret M; Boileau C; Magot T; Krempf M
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1448-53. PubMed ID: 15166014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.
    Ooi EM; Barrett PH; Watts GF
    Int J Cardiol; 2013 Oct; 168(3):1811-8. PubMed ID: 23907036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of functional low-density lipoprotein receptor activity on lymphocytes of normal subjects and patients with familial hypercholesterolemia.
    Cuthbert JA; Lipsky PE
    Trans Assoc Am Physicians; 1988; 101():1-11. PubMed ID: 3269672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
    Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Brewer HB
    J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
    Teng B; Sniderman AD; Soutar AK; Thompson GR
    J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
    Tremblay AJ; Lamarche B; Ruel I; Hogue JC; Bergeron J; Gagné C; Couture P
    Atherosclerosis; 2004 Feb; 172(2):367-73. PubMed ID: 15019548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis.
    Barnard GF; Erickson SK; Cooper AD
    J Clin Invest; 1984 Jul; 74(1):173-84. PubMed ID: 6330173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.
    Rubinsztein DC; Cohen JC; Berger GM; van der Westhuyzen DR; Coetzee GA; Gevers W
    J Clin Invest; 1990 Oct; 86(4):1306-12. PubMed ID: 2212015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
    Soutar AK; McCarthy SN; Seed M; Knight BL
    J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein binding to cultured human hepatoma cells.
    Krempler F; Kostner GM; Friedl W; Paulweber B; Bauer H; Sandhofer F
    J Clin Invest; 1987 Aug; 80(2):401-8. PubMed ID: 3038957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.